(MENAFN- EIN Presswire) Antiemetics Market 2023
The report includes analysis of the regional and global antiemetics market trends, key players, market segments, application areas,& market growth strategies.
PORTLAND, OREGON, UNITED STATES, April 20, 2023 /einpresswire.com / -- Allied Market Research has published a study report with the title antiemetics market size was Valued at USD 2.3 billion in 2021 and is Projected to Garner USD 4.1 billion by 2031, registering a CAGR of 6.1% from 2022 to 2031.
This report provides a comprehensive overview of the Antiemetics Market, including an in-depth analysis of market trends, key segments, investment opportunities, value chain analysis, regional landscape, and competitive scenarios. It offers valuable insights for established market players, new entrants, investors, and other stakeholders to devise effective strategies and make informed decisions to enhance their market position. The report is a valuable resource for anyone seeking to gain a deeper understanding of the Antiemetics Market and its growth potential in the future.
The growth of the antiemetics market is attributed to the increase in the prevalence of nausea and vomiting due to the conditions such as motion sickness, morning sickness during pregnancy, severe cases of stomach flu, and other infections. The new product launches and product approvals for the treatment of nausea and vomiting by the public and private players will provide a lucrative opportunity for the market. Also, the increase in strategic initiatives such as mergers, collaborations, and acquisitions, by leading players is expected to provide favorable environment for the growth of the market Covid-
Get Sample PDF Report with Graphs and Figures Here:
Market Overview:
Antiemetic drugs such as aprepitant, dexamethasone, dolasetron, granisetron, ondansetron, palonosetron, prochlorperazine, and rolapitant are used to prevent nausea and vomiting conditions in patients. Nausea and vomiting may be caused due to various ailments such as motion sickness, morning sickness during pregnancy, severe cases of stomach flu, and other infections. In addition, nausea and vomiting are common parts of chemotherapy treatment, which leads to rise in demand for antiemetic medications.
KEY FINDINGS OF THE STUDY
.On the basis of drug type, the serotonin receptor antagonists segment held the largest market share in 2021, and is expected to remain dominant during the forecast period.
.On the basis of application, the chemotherapy segment held the largest antiemetics market share in 2021, whereas the post operative surgery segment is expected to remain dominant during the forecast period.
.On the distribution channel, the retail pharmacies segment held largest market share in 2021, whereas the online pharmacies is expected to grow at the fastest CAGR rate during the forecast period.
.Region-wise, North America held the largest share of the antiemetics industry in the year 2021, whereas the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period
✅ Top Antiemetics Companies
.GlaxoSmithKline Plc
.Sanofi
.Novartis AG
.Pfizer Inc
.Merck & Co. Inc
.Dr. Reddy's Laboratories Ltd
.Cipla
.Johnson & Johnson
.Torrent Pharmaceuticals Ltd
.Acacia Pharma Group
✅ Antiemetics Market Segmentation: –
The global antiemetics market analysis is segmented on the basis of drug type, application, distribution channel, and region.
By Drug Type
.Antihistamines
.Serotonin Receptor Antagonists
.Dopamine Receptor Antagonists
.Neurokinin Receptor Antagonists
.Anticholinergics
.Other Drug Types
By Application
.Chemotherapy
.Post Operative Surgery
.Pregnancy and Gatroenteritis
.Other Applications
By Distribution Channel
.Retail Pharmacies
.Hospital Pharmacies
.Online Pharmacies
North America acquired major of the antiemetics market share in 2021, owing to the presence of key players, rising government initiatives, well-developed healthcare infrastructure, and rising prevalence of health issues. However, Asia-Pacific is expected to register highest CAGR from 2022 to 2031, owing to the rapid changes in the environmental conditions and associated viral and bacterial disease which causes nausea and vomiting.
Purchase the Report:
Our Market Research Solution Provides You Answer to Below Mentioned Question:
.Which are the driving factors responsible for the growth of market?
.Which are the roadblock factors of this market?
.What are the new opportunities, by which market will grow in coming years?
.What are the trends of this market?
.Which are main factors responsible for new product launch?
.How big is the global & regional market in terms of revenue, sales and production?
.How far will the market grow in forecast period in terms of revenue, sales and production?
.Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
.How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
.Which region has more opportunities?
By Region Outlook
. North America
(U.S., Canada, Mexico)
. Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
. Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
. LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Top Trending Report:
.Gene Therapy Market:
.3D Cell Culture Market:
.Molecular diagnostics market:
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here